HbA1c

Estimated Average Glucose (eAG)

If you have diabetes, you are almost certainly familiar with HbA1c — the blood test that gives a snapshot of your average blood sugar control over the past two to three months. It is the cornerstone of diabetes monitoring worldwide, used by clinicians to assess how well blood sugar has been managed, to guide treatment decisions, and to predict the risk of long-term complications. But HbA1c is reported as a percentage — or in some countries as mmol/mol — and for many people, that number is difficult to relate to the day-to-day blood sugar readings they see on their glucometer or continuous glucose monitor. A result of 7.5% does not immediately tell you what your blood sugar was averaging on a typical Tuesday morning.

This is exactly the gap that the HbA1c to Average Glucose converter fills. It translates your HbA1c result into an Estimated Average Glucose (eAG) — expressed in the same mg/dL or mmol/L units you see on your blood sugar meter every day. The conversion makes your three-month average blood sugar immediately tangible and comparable to your self-monitored readings, giving you a much more intuitive understanding of what your HbA1c actually represents in real-world glucose terms.

The formula used for this conversion was developed through the landmark ADAG study — A1c-Derived Average Glucose — published in 2008, which measured actual average blood glucose levels in over 500 people with Type 1 and Type 2 diabetes using continuous glucose monitoring and frequent fingerstick testing, and then mathematically mapped those averages to their corresponding HbA1c values. The result was the linear equation now used universally by the American Diabetes Association (ADA) and adopted in clinical practice globally.

Formula Used

This calculator uses the ADAG formula — the internationally validated equation endorsed by the American Diabetes Association for converting HbA1c to Estimated Average Glucose:

eAG (mg/dL) = ( 28.7 × HbA1c% ) − 46.7

eAG (mmol/L) = ( ( 28.7 × HbA1c% ) − 46.7 ) ÷ 18.02

For users whose HbA1c is reported in mmol/mol — the IFCC unit used in the United Kingdom, Australia, and many European countries — the calculator first converts to the NGSP percentage unit before applying the formula:

HbA1c (%) = ( HbA1c mmol/mol ÷ 10.929 ) + 2.15

The calculator also performs the reverse conversion — displaying your HbA1c in both units simultaneously — so that you can see both the NGSP percentage and the IFCC mmol/mol equivalent regardless of which unit your laboratory uses:

HbA1c (mmol/mol) = ( HbA1c% − 2.15 ) × 10.929

To put the main formula in concrete terms — an HbA1c of 7.0% converts to an eAG of:

( 28.7 × 7.0 ) − 46.7 = 200.9 − 46.7 = 154.2 mg/dL (or 8.6 mmol/L)

An HbA1c of 6.5% — the diagnostic threshold for diabetes — converts to an eAG of approximately 140 mg/dL (7.8 mmol/L). These numbers help contextualize what HbA1c targets mean in terms of day-to-day blood sugar levels, which is something many patients find far more meaningful than the percentage alone.

How to Use the Calculator?

1. 1. Find your most recent HbA1c result from your blood test report.
2. 2. Select your HbA1c unit — percentage (%) or mmol/mol.
3. 3. Enter your HbA1c value.
4. 4. Click Calculate.
5. 5. Your Estimated Average Glucose will be displayed in both mg/dL and mmol/L, along with your HbA1c expressed in both percentage and mmol/mol units.

Understanding Your Results

The table below shows the relationship between common HbA1c values, their mmol/mol equivalents, and the corresponding estimated average glucose in both units — based on the ADAG formula used by the American Diabetes Association:

The ADA currently recommends an HbA1c target of below 7.0% (53 mmol/mol) for most non-pregnant adults with diabetes — corresponding to an average blood sugar of approximately 154 mg/dL (8.6 mmol/L). More stringent targets of below 6.5% may be appropriate for some younger patients with short disease duration and no significant hypoglycemia risk. Less stringent targets of below 8.0% are appropriate for older adults, those with frequent hypoglycemia unawareness, or those with limited life expectancy — where the risks of tight control outweigh the benefits.

Clinical Significance

HbA1c is one of the most measured laboratory values in medicine — and this converter makes it genuinely meaningful to the people whose health it reflects.

1. 1. Bridging the gap between clinic and daily life is the most immediate value of this converter. Most people with diabetes check their blood sugar in mg/dL or mmol/L every day — but their HbA1c comes back as a percentage that feels abstract and disconnected from those daily numbers. Knowing that an HbA1c of 8.0% corresponds to an average blood sugar of 183 mg/dL immediately makes that result concrete, personal, and actionable in a way the percentage alone never does.
2. 2. Treatment target setting becomes more intuitive when expressed as an average glucose rather than a percentage. Telling a patient their target HbA1c is 7.0% is less immediately motivating than telling them the goal is an average blood sugar of around 154 mg/dL — a number they can directly compare against the readings they are already seeing on their meter or CGM every day.
3. 3. CGM data interpretation benefits from eAG conversion because most continuous glucose monitors report a metric called GMI — Glucose Management Indicator — which is essentially an HbA1c estimate derived from CGM data using a similar formula. Comparing eAG from a lab HbA1c with the average glucose reported by a CGM helps users understand whether their CGM data aligns with their laboratory result — or whether a discrepancy exists that needs investigation.
4. 4. Diabetes diagnosis communication is improved when HbA1c is translated into average glucose terms. The diagnostic threshold of 6.5% means more to a patient when they understand it corresponds to an average blood sugar of 140 mg/dL — a level that is persistently above the normal fasting range and associated with the beginning of microvascular damage over time.
5. 5. Dual unit reporting — showing HbA1c in both % and mmol/mol simultaneously — resolves a genuine source of confusion for people who receive care in different countries or compare results with international resources. A patient who moves from Pakistan to the United Kingdom, for example, will suddenly see their HbA1c reported in mmol/mol rather than percentage — this converter allows them to translate between the two instantly.
6. 6. Long-term complication risk becomes more tangible when framed in average glucose terms. The Diabetes Control and Complications Trial (DCCT) and UK Prospective Diabetes Study (UKPDS) — the landmark studies that established the relationship between HbA1c and complications — showed that every 1% reduction in HbA1c corresponds to meaningful reductions in retinopathy, nephropathy, and neuropathy risk. Expressing this as a reduction in average blood glucose of approximately 29 mg/dL per 1% HbA1c reduction gives that finding immediate real-world meaning.
7. 7. Patient education and diabetes literacy are genuinely improved by tools that translate clinical metrics into everyday language. People who understand what their HbA1c means in terms of their actual blood sugar levels are more engaged in their own management, more motivated to make changes, and more likely to adhere to treatment plans — all of which translates to better outcomes over time.

Limitations of HbA1c to Average Glucose Converter

The ADAG formula is the best available tool for this conversion — but the relationship between HbA1c and average glucose is not as clean or universal as the formula implies.

1. 1. HbA1c does not reflect glucose variability. Two people can have exactly the same HbA1c — and therefore the same eAG — yet have completely different glucose patterns. One may be consistently near target all day. The other may swing from dangerous highs to dangerous lows that average out to the same number. The eAG hides this variability entirely, which is one of the main reasons continuous glucose monitoring and time-in-range metrics are increasingly preferred over HbA1c alone as measures of glycemic control quality.
2. 2. Red blood cell lifespan affects HbA1c independently of blood sugar. HbA1c reflects the glycation of hemoglobin over the lifespan of red blood cells — typically around 90 to 120 days. Conditions that shorten red blood cell lifespan — including hemolytic anemia, sickle cell disease, iron deficiency anemia, and certain hemoglobin variants — artificially lower HbA1c independently of actual blood sugar levels. In these patients, HbA1c significantly underestimates true average glucose and the eAG conversion will be equally misleading.
3. 3. Certain conditions falsely elevate HbA1c without a corresponding increase in average glucose — including iron deficiency anemia, vitamin B12 deficiency, and splenectomy. In these cases, eAG will overestimate true average blood sugar.
4. 4. Ethnic variation in the HbA1c to glucose relationship is a recognized and clinically important limitation. Studies have shown that people of African, African-American, and some Asian descent tend to have higher HbA1c values for the same average glucose level compared to people of European descent — meaning the ADAG formula, which was developed predominantly in a mixed but majority Caucasian population, may overestimate true average glucose in these groups.
5. 5. The eAG represents a weighted average that is not uniformly distributed across the day or across the three-month period. Because red blood cells of different ages contribute differently to the HbA1c measurement — with more recently glycated cells contributing more — HbA1c is more heavily influenced by blood sugar levels in the most recent 4 to 6 weeks than by those from two or three months ago. The eAG does not reflect this temporal weighting.
6. 6. Pregnancy alters the HbA1c to glucose relationship due to changes in red blood cell turnover and hemoglobin metabolism. HbA1c tends to run lower in pregnancy for physiological reasons unrelated to blood sugar control — making eAG conversion less reliable in pregnant women with diabetes.
7. 7. Laboratory assay variation affects HbA1c measurement similarly to fasting insulin — different laboratory platforms and methods can produce slightly different HbA1c values from the same blood sample, which flows directly into the eAG calculation. Always interpret results in the context of your specific laboratory's methodology and reference ranges.
8. 8. For a complete picture of glycemic control, HbA1c and eAG should be interpreted alongside:
   1. - CGM time-in-range (70–180 mg/dL target)
   2. - Glucose variability metrics (standard deviation, coefficient of variation)
   3. - Frequency and severity of hypoglycemic episodes
   4. - Fasting and postprandial glucose readings
   5. - Full clinical review by an endocrinologist or diabetes care specialist

Disclaimer

This HbA1c to Average Glucose converter is for educational and informational purposes only and does not constitute medical advice or diagnosis.

The eAG value generated is a mathematical estimate based on a population-derived formula and may not accurately reflect individual average glucose in people with conditions affecting red blood cell lifespan, hemoglobin variants, pregnancy, or certain ethnic backgrounds where the HbA1c to glucose relationship differs from the study population on which the formula was developed.

Do not use this result to make changes to your diabetes medication, insulin doses, or treatment plan without consulting your diabetes care team. If your HbA1c result is outside your target range, speak with your endocrinologist or diabetes nurse specialist.

We do not store or share any data you enter. The creators of this tool accept no liability for decisions made based on its output.